SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-076218
Filing Date
2024-06-21
Accepted
2024-06-21 16:05:11
Documents
11
Period of Report
2024-06-20
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K onct-20240620.htm   iXBRL 8-K 56254
  Complete submission text file 0000950170-24-076218.txt   172119

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT onct-20240620.xsd EX-101.SCH 26616
14 EXTRACTED XBRL INSTANCE DOCUMENT onct-20240620_htm.xml XML 4715
Mailing Address 12230 EL CAMINO REAL SUITE 230 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 230 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Filer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50549 | Film No.: 241060140
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)